| Penicillamine-induced ocular myasthenia gravis in rheumatoid arthritis. | |
| | |
MedLine Citation:
|
PMID: 2144538 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
We report a case of a 47-year-old woman with rheumatoid arthritis who developed ocular myasthenia gravis during penicillamine treatment. Her serum contained elevated titers of acetylcholine receptor antibodies, and her symptoms resolved 8 weeks after discontinuation of penicillamine. We review the clinical and laboratory features of this syndrome of penicillamine-induced myasthenia gravis and discuss its pathophysiology and treatment. |
| | |
Authors:
|
G T Liu; D C Bienfang |
Related Documents
:
|
7651698 - Orbital inflammatory syndrome: an unusual presentation. 21413148 - Identification of autoantibody biomarkers for primary sjögren's syndrome using protein... 1117298 - A study of sensitivity to curare in myasthenic disorders using a regionaltechnique. 9121508 - Stiff-persons' syndrome associated with thymoma and subsequent myasthenia gravis. 21747838 - Systemic role for vitamin d in the treatment of psoriasis and metabolic syndrome. 16166968 - Tumor lysis syndrome: pathophysiology, definition, and alternative treatment approaches. |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Journal of clinical neuro-ophthalmology Volume: 10 ISSN: 0272-846X ISO Abbreviation: J Clin Neuroophthalmol Publication Date: 1990 Sep |
Date Detail:
|
Created Date: 1990-10-17 Completed Date: 1990-10-17 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 8109051 Medline TA: J Clin Neuroophthalmol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 201-5 Citation Subset: IM |
Affiliation:
|
Division of Neurology, Brigham and Women's Hospital, Boston, MA 02115. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Arthritis, Rheumatoid
/
complications*,
drug therapy,
physiopathology Diplopia / chemically induced, complications, physiopathology Female Humans Middle Aged Myasthenia Gravis / chemically induced*, complications, physiopathology Ocular Motility Disorders / chemically induced*, complications, physiopathology Oculomotor Muscles / drug effects Penicillamine / adverse effects* Receptors, Cholinergic / blood |
| Chemical | |
Reg. No./Substance:
|
0/Receptors, Cholinergic; 52-67-5/Penicillamine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Anterior ischemic optic neuropathy and branch retinal artery occlusion in cavernous sinus thrombosis...
Next Document: Diabetic complete external ophthalmoplegia.